Lupin stock rises nearly 3% after US FDA approves Allopurinol tablets
Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for Allopurinol tablets USP, 100 mg and 300 mg. The drug will be manufactured at Lupin’s Pithampur facility in India.
Lupin Share Price: Lupin shares gained momentum at the morning trading session on Monday (December 18, 2023) as the company got approval from the US FDA for two of its medicines which will be used in diabetes treatment.
The Lupin stock was trading higher by 2.93 per cent, or Rs 36.50, at Rs 1282.15 at 9:38 am on Monday. The company's market cap at the time of writing this news stood at Rs 58,322.45 crore.
"Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its
Abbreviated New Drug Application for Allopurinol Tablets USP, 100 mg and 300 mg to market a generic equivalent to the reference listed drug (RLD), Zyloprim Tablets, 100 mg, and 300 mg, of Casper Pharma, LLC," said Lupin in a statement.
The product will be manufactured at Lupin’s Pithampur facility in India.
The market size for both the tablets is estimated to be Rs.730 crore.
The medicines will be used for adult patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy), among other treatments.
What analyst says about Lupin stock
Zee Business analyst Varun Dubey has recommended buying the Lupin stock. He has given the target of Rs 1280 with stop loss at Rs 1235.
Nifty Pharma Index
The Nifty Pharma index was higher by 1.44 per cent, or 233.65, at 16413.45 at 11:31 am on Monday.
The index's rise in the one month has been 3.84 per cent.
It has soared by 23.74 per cent in the six months and 30.77 per cent year to date.
The benchmark Nifty 50 index, meanwhile, has jumped by 9.03 per cent in the one month; 14.49 per cent in the six months, and 18.00 per cent year to date.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SBI Senior Citizen FD Rates: What Rs 1 lakh, Rs 3 lakh, and 5 lakh investments will give you in 1-, 3- and 5-year FDs
Top 7 SIP Mutual Funds in 1 Year: What Rs 10,000, Rs 15,000, and Rs 20,000 SIPs have given in each fund
IPL 2024 Eliminator Ticket Booking: Where and how to buy IPL Playoffs Eliminator match tickets online - Check ticket price, other details
Dividend, bonus, stock split stocks next week: SBI, Trent, Colgate Palmolive, Bharat Dynamics, Tata Consumer Products, other stocks to trade ex-date
Top Large-cap vs flexi-cap vs ELSS mutual fund: Which fund has given maximum returns in SIP and lump sum in 3 years
11:36 AM IST